| Surname, First name |
Research Focus |
Availability |
| Ertürk, Ali |
Project 1: 3D Proteomic Maps / Project 2: Targeted Delivery of Nucleic Acid Therapeutics via Lipid Nanoparticles |
available in 2026 |
| Michalakis, Stylianos |
Engineered adeno-associated virus-based vectors for retinal gene therapy - Mechanistic studies on cellular infection, trafficking and transduction |
TBA |
| Misgeld, Thomas |
The Misgeld lab uses in vivo imaging methods (ranging from wide-field time-lapse to two-photon microscopy) to study the development and degeneration of neurons and their processes. |
TBA |
| Plesnila, Nikolaus |
Single-Cell Transcriptomics of Stroke and Nitric Oxide Treatment: Investigating Microglia and Neuronal Responses in Mice |
not available |
| Ploner, Markus |
On a systems neuroscience level we are working on the brain mechanisms of pain perception. We aim to further the understanding of the brain processes, which determine the individual sensitivity of a person to pain, which explain why we perceive the same painful event differently in different situations. |
TBA |
| Sattler, Michael |
The student will contribute to the cloning of expression constructs, recombinant protein production, and purification, forming the foundation for the structural and functional studies. Through this work, we aim to uncover key aspects of the Grp94 functional cycle, providing insights that are fundamental for understanding ER proteostasis and may ultimately inform future drug discovery efforts targeting Grp94. |
available in 2026 |
| Schmidt, Mathias V. |
We aim to elucidate the role of the chaperone protein FKBP51 (FK506-binding protein 51) in the regulation of EV release. |
available in 2026 |
| Tiedt, Steffen |
We aim to identify circulating signatures that inform on the local and systemic effects of stroke and to explore the underlying molecular and pathophysiological mechanisms. Events in most organs including the local and systemic events (e.g. stress) related to acute stroke are captured by the circulating proteome and metabolome. |
not available |
| Vollmar, Angelika |
The biochemical pathway of chlorophyll degradation has only recently been characterized. The metabolites that are yielded from the breakdown path – the phyllobilins – were shown to have antioxidant properties. |
TBA |
| Willem, Michael |
Alzheimer’s disease (AD) is the main cause of dementia and a clear challenge for modern public health. Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed by microglia, and sequence variants have been identified as risk factors for AD. The project will address the direct interaction of soluble TREM proteins with candidate receptors using site-directed mutagenesis and functional assays to monitor the effects on the interaction and activity in cell culture and in vitro. |
available in 2026 |
